Investors Buy High Volume of Put Options on Evelo Biosciences

 Evelo Biosciences, Inc. (NASDAQ:EVLO - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders bought 1,885 put options on the stock. This represents an increase of approximately 1,101% compared to the typical volume of 157 put options.

In other Evelo Biosciences news, major shareholder Ventures Fund Iv Gene Flagship bought 5,411,255 shares of the firm's stock in a transaction dated Tuesday, July 11th. The shares were purchased at an average cost of $2.31 per share, for a total transaction of $12,499,999.05. Following the transaction, the insider now owns 3,931,685 shares of the company's stock, valued at $9,082,192.35. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, major shareholder Ventures Fund Iv Gene Flagship bought 5,411,255 shares of Evelo Biosciences stock in a transaction dated Tuesday, July 11th. The shares were acquired at an average price of $2.31 per share, with a total value of $12,499,999.05. Following the completion of the purchase, the insider now owns 3,931,685 shares in the company, valued at approximately $9,082,192.35. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Mark Bodmer sold 3,128 shares of Evelo Biosciences stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $9.51, for a total transaction of $29,747.28. Following the transaction, the insider now directly owns 16,624 shares of the company's stock, valued at $158,094.24. The disclosure for this sale can be found here. Insiders sold 5,474 shares of company stock worth $52,058 over the last 90 days. 4.00% of the stock is owned by insiders.

https://www.marketbeat.com/instant-alerts/nasdaq-evlo-options-data-report-2023-08-24/